Seer, Inc. – NASDAQ:SEER
Founder-led company
Seer stock price today
$2.05
-0.20
-9.29%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 13 hours
Seer stock price monthly change
+21.50%
month
Seer stock price quarterly change
+21.50%
quarter
Seer stock price yearly change
+19.58%
year
Seer key metrics
Market Cap | 134.73M |
Enterprise value | 218.28M |
P/E | -2.5 |
EV/Sales | 14.08 |
EV/EBITDA | -2.40 |
Price/Sales | 15.59 |
Price/Book | 0.54 |
PEG ratio | 0.08 |
EPS | -1.30 |
Revenue | 14.52M |
EBITDA | -95.64M |
Income | -82.99M |
Revenue Q/Q | -17.53% |
Revenue Y/Y | -3.79% |
Profit margin | -600.05% |
Oper. margin | -627.61% |
Gross margin | 45.78% |
EBIT margin | -627.61% |
EBITDA margin | -658.26% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSeer stock price history
Seer stock forecast
Seer financial statements
| Jun 2023 | 3.47M | -23.43M | -675.24% |
|---|---|---|---|
| Sep 2023 | 3.81M | -21.08M | -552.91% |
| Dec 2023 | 4.17M | -17.79M | -425.81% |
| Mar 2024 | 3.06M | -20.67M | -674.46% |
| Mar 2024 | 3.06M | -20.67M | -674.46% |
|---|---|---|---|
| Sep 2025 | 7.05M | -16.36M | -232.06% |
| Oct 2025 | 5.45M | -19.69M | -361.44% |
| Dec 2025 | 7.05M | -18.08M | -256.51% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 461195000 | 43.07M | 9.34% |
|---|---|---|---|
| Sep 2023 | 444853000 | 39.17M | 8.81% |
| Dec 2023 | 436269000 | 39.36M | 9.02% |
| Mar 2024 | 421962000 | 38.40M | 9.1% |
| Jun 2023 | -15.13M | 22.93M | 212K |
|---|---|---|---|
| Sep 2023 | -14.41M | -5.62M | 28K |
| Dec 2023 | -10.19M | 6.11M | 182K |
| Mar 2024 | -10.45M | 32.35M | 0 |
Seer alternative data
| Aug 2023 | 164 |
|---|---|
| Sep 2023 | 164 |
| Oct 2023 | 164 |
| Nov 2023 | 164 |
| Dec 2023 | 164 |
| Jan 2024 | 164 |
| Feb 2024 | 164 |
| Mar 2024 | 147 |
| Apr 2024 | 147 |
| May 2024 | 147 |
| Jun 2024 | 147 |
| Jul 2024 | 147 |
Seer other data
32.78%
-36.16%
of SEER is owned by hedge funds
52
-44
20.46M
-22.65M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 0 | 1468 |
| Aug 2023 | 40000 | 0 |
| Dec 2023 | 0 | 8182 |
| Feb 2024 | 0 | 28976 |
| Mar 2024 | 0 | 52857 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | FAROKHZAD OMID director, officer.. | Class A Common Stock | 52,857 | $2.03 | $107,405 | ||
Sale | KOGAN ELONA officer: CHIEF LEGAL OFFICER | Class A Common Stock | 12,684 | $1.58 | $20,028 | ||
Sale | HORN DAVID R. officer: PRESIDEN.. | Class A Common Stock | 12,684 | $1.58 | $20,028 | ||
Sale | HORN DAVID R. officer: Presiden.. | Class A Common Stock | 3,608 | $1.67 | $6,015 | ||
Sale | KOGAN ELONA ESQ. officer: Chief Legal Officer | Class A Common Stock | 8,182 | $1.7 | $13,868 | ||
Option | FAROKHZAD OMID director, officer.. | Class A Common Stock | 151,764 | $0.04 | $6,071 | ||
Option | FAROKHZAD OMID director, officer.. | Employee Stock Option (right to buy) | 151,764 | $0.04 | $6,071 | ||
Purchase | FAROKHZAD OMID director, officer.. | Class A Common Stock | 40,000 | $2.45 | $97,960 | ||
Sale | THOMAS SCOTT D officer: Chief Commercial Officer | Class A Common Stock | 1,468 | $3.56 | $5,225 | ||
Sale | HORN DAVID R. officer: Chief Fi.. | Class A Common Stock | 5,951 | $4.14 | $24,607 |
| Patent |
|---|
Application Filling date: 3 Nov 2021 Issue date: 18 Aug 2022 |
Application Filling date: 29 Mar 2021 Issue date: 16 Sep 2021 |
Application Filling date: 29 Mar 2021 Issue date: 16 Sep 2021 |
Application Filling date: 29 Mar 2021 Issue date: 15 Jul 2021 |
Application Filling date: 29 Mar 2021 Issue date: 15 Jul 2021 |
Application Filling date: 12 Oct 2020 Issue date: 1 Apr 2021 |
Application Filling date: 22 Aug 2019 Issue date: 6 Feb 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 1 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Seer stock today?
One share of Seer stock can currently be purchased for approximately $2.05.
-
When is Seer's next earnings date?
Unfortunately, Seer's (SEER) next earnings date is currently unknown.
-
Does Seer pay dividends?
No, Seer does not pay dividends.
-
How much money does Seer make?
Seer has a market capitalization of 134.73M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.38% to 15.18M US dollars.
-
What is Seer's stock symbol?
Seer, Inc. is traded on the NASDAQ under the ticker symbol "SEER".
-
What is Seer's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Seer?
Shares of Seer can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Seer's key executives?
Seer's management team includes the following people:
- Dr. Omid C. Farokhzad Ph.D., M.D. Founder, Chief Executive Officer & Chair of the Board of Directors(age: 56, pay: $972,080)
- Mr. Omead Ostadan Pres, Chief Operating Officer & Director (Leave of Absence)(age: 53, pay: $745,740)
- Mr. David R. Horn Executive Vice President & Chief Financial Officer(age: 57, pay: $554,290)
-
Is Seer founder-led company?
Yes, Seer is a company led by its founder Dr. Omid C. Farokhzad Ph.D., M.D..
-
How many employees does Seer have?
As Jul 2024, Seer employs 147 workers.
-
When Seer went public?
Seer, Inc. is publicly traded company for more then 4 years since IPO on 4 Dec 2020.
-
What is Seer's official website?
The official website for Seer is seer.bio.
-
Where are Seer's headquarters?
Seer is headquartered at 3800 Bridge Parkway, Redwood City, CA.
-
How can i contact Seer?
Seer's mailing address is 3800 Bridge Parkway, Redwood City, CA and company can be reached via phone at +65 04530000.
Seer company profile:
Seer, Inc.
seer.bioExchange:
NASDAQ
Full time employees:
147
Industry:
Biotechnology
Sector:
Healthcare
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
3800 Bridge Parkway
Redwood City, CA 94065
Redwood City, CA 94065
CIK: 0001726445
ISIN: US81578P1066
CUSIP: 81578P106
